Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J7VA
|
||||
Former ID |
DNC013986
|
||||
Drug Name |
Isorhamnetin 3-O-rhamnoside
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [526409] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H22O11
|
||||
Canonical SMILES |
CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C<br />4)O)OC)O)O)O
|
||||
InChI |
1S/C22H22O11/c1-8-16(26)18(28)19(29)22(31-8)33-21-17(27)15-12(25)6-10(23)7-14(15)32-20(21)9-3-4-11(24)13(5-9)30-2/h3-8,16,18-19,22-26,28-29H,1-2H3/t8-,16-,18+,19+,22-/m0/s1
|
||||
InChIKey |
UXXAEVMOIUAYQT-UFGFRKJLSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Aldose reductase | Target Info | Inhibitor | [526409] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.